CryoCath seek to build Euro endorsements:
This article was originally published in Clinica
Boosting European acceptance of CryoCath Technologies' Freezor tachyarrythmia system is the name of the game for the Kirkland, Quebec company, as it seeks to build endorsement of the system. The European roll-out continues this and next year, and a US launch is targeted for 2003. A recent live telecast of a cardiac arrythmia cryoablation procedure using Freezor will have done much to generate interest in catheter cryotherapy, believes CryoCath. The procedure was carried out at the 2001 Global Endovascular Therapy conference, in Monaco, France. Ten European hospitals use the Freezor system.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.